Reagent for interfering with expression of hsa-mir-449a and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHONGQING PRECISION BIOTECH CO LTD
- Publication Date
- 2020-08-11
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of genetic engineering, and relates to a reagent for interfering with the expression of Hsa-miR-449a and its application, in particular to the application in the preparation of a drug for inhibiting the self-renewal of liver cancer stem cells. Background technique
[0002] Liver cancer is one of the most common malignant tumors in the world. Its pathogenesis has not yet been clarified. The current treatment of liver cancer is not ideal. Postoperative recurrence and metastasis are still a major problem to be solved. Recent studies have made the concept of cancer stem cells (CSCs) deeply rooted in the hearts of the people, and more and more evidences show that CSCs are closely related to tumor growth, drug resistance, recurrence and metastasis. So far, the existence of tumor stem cells has been confirmed in more than 30 common tumors such as blood system tumors, glioma, liver cancer, breast cancer, and colorectal cancer...